Ayala Pharmaceuticals Inc (ADXS)

[cab033]

Institutional ownership has been droping for the last 3 years. I started pointing this out the 1st Qtr it started to drop, but the message was never received well by the MB. From a high of roughly 80% to a current low of 33%. Not good. That also corresponds pretty closely to the SP high of $30 to the current low of $1.xx over the last 3 years. Not manipulation, just SP demand. Also not the Executive level turnover over the same 3 year range. All the pieces are there. Just gotta look at them all and put them together.

Looking forward, what has changed (as in the inverse of the above)? Heavy Institution buying? No. Amazing data/PR/news? No. Top level CEO/CFO? No/no. Likely near term substantial event? Other than the same whishful possibility the past 3 years has provided, no.

So... Yes another r/s is an option, near term ATL dilution is likely, being a permanant single digit stock is possible, getting a BO offer (been talked about for many many years but here it is sitting in the $1's) highly unlikely based on past and current events/situation.